by imavexadmin | Nov 9, 2022 | Uncategorized
Insights Our Blog Advice to Pharmacy Students Interested in Consulting or Non-Pharmacy Avenues As a pharmacy student in the mid 90’s, it wasn’t abundantly clear what my career prospects were beyond retail or hospital pharmacy (maybe I wasn’t paying attention)....
by imavexadmin | Sep 23, 2022 | Uncategorized
Insights Our Blog Keith Chop Spotlight Meet Keith Chop, Managing Partner at Alinea Group. Keith is based in Alinea’s Indianapolis office, and he is passionate about healthcare consulting and developing lasting relationships with his clients. Keith has an extensive...
by imavexadmin | Aug 12, 2022 | Uncategorized
Insights Our Blog Alinea Group Spotlight Interview: Anna-Marie Oakes Anna-Marie is a pharmacist and 340B subject matter expert, and she brings first-hand experience from the covered entity perspective. Anna-Marie recognizes the challenges of regulatory compliance in...
by imavexadmin | Aug 8, 2022 | Uncategorized
Insights Our Blog 2022 340B Summer Conference Recap Patient Definition Developments, Implications of Drug Pricing Bill, and Strong Statements Against Manufacturer Contract Pharmacy Restrictions Highlight This Year’s Conference Our nation’s capital was buzzing...
by imavexadmin | Jul 21, 2022 | Uncategorized
Insights Our Blog Alinea Group Spotlight Interview: Shrujal Patel Shrujal Patel, Managing Partner at Alinea Group, was recently interviewed by 340B Report. He shares about his background, how he became involved in this space, and some advice for young professionals....
by Tim Olmstead | Jun 23, 2022 | Uncategorized
Insights Our Blog Key Considerations for Streamlining 340B ESP Use: Blog by Curtis Frazier Alas, after much deliberation, your covered entity has decided to submit data to 340B ESP. As you embark on this journey, you may be asking yourself: Now what?!? As someone...
